skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 252918 Find in a Library
Title: Novel Blood Protein Modification Assay for Retrospective Detection of Drug Exposure
Author(s): Anthony P. DeCaprio
Corporate Author: Florida International University
United States of America
Date Published: 05//2019
Page Count: 50
Sponsoring Agency: Florida International University
Miami, FL 33199
National Institute of Justice (NIJ)
Washington, DC 20531
US Dept of Justice NIJ Pub
Washington, DC 20531
Grant Number: 2015-NE-BX-K001
Sale Source: US Dept of Justice NIJ Pub
810 Seventh Street, NW
Washington, DC 20531
United States of America
Document: PDF
Type: Program/Project Description; Report (Grant Sponsored); Report (Study/Research); Report (Summary); Research (Applied/Empirical)
Format: Document; Document (Online)
Language: English
Country: United States of America
Annotation: This report summarizes the methodology and findings of a project whose purpose was to produce basic research data and preliminary applied data to support the ultimate goal of developing protein adduct-based biomarkers assays for compounds of forensic interest, including drugs of abuse.
Abstract: The project anticipated that such tools would enable drug exposure assessment for these compounds over a longer period of time than is currently possible, as well as provide an alternative or complement to the customary hair analysis. A potential technology for longer term monitoring of drug exposure involves the measurement of the products of covalent modification of free moleties of blood proteins, such as hemoglobin (Hb) and serum albumin (SA) by reactive metabolites (RM) of drugs. Since they typically persist for the life of the protein, such protein “adducts” can provide a much longer period for detection of exposure to drugs than is generally possible by direct measurement of parent compound or a metabolite. Although widely used in human exposure assessment for environmental and occupational chemicals, applications of protein adducts as markers of illicit drug exposure are virtually nonexistent. The current project’s preliminary studies demonstrate that in vitro modification of glutathione (GSH) and model thiol that contains peptides by RM of certain abused drugs is potentially feasible as a means of identifying drug exposure over a longer period of time since exposure. This report advises that this project has made a key step toward developing a useful drug monitoring strategy based on blood protein modification that will lead to the next stage, which will involve the development and validation of a practical assay. Implications of these project results are drawn for criminal justice policy and practice in the United States. 18 figures, 4 tables, and a listing of presentations and publications of project results
Main Term(s): Forensic sciences
Index Term(s): Blood/body fluid analysis; Drug detection; Drug testing; Drug use; Drug Use Indicators; Investigative techniques; National Institute of Justice (NIJ); NIJ final report
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.